• Fund Type: ETF
  • Objective: Eurozone
  • Asset Class: Equity
  • Geographic Focus: Eurozone

iShares STOXX Europe 50 UCITS ETF DE

+ Add to Watchlist

SX5PEX:GR

30.9000 EUR 0.0500 0.16%

As of 15:45:04 ET on 09/17/2014.

Snapshot for iShares STOXX Europe 50 UCITS ETF DE (SX5PEX)

Open: 30.8700 High - Low: 30.9500 - 30.8400 Primary Exchange: Xetra ETF
Volume: 4,000 52-Week Range: 27.4100 - 31.5000 Beta vs SX5R: 0.9592

ETF Chart for SX5PEX

No chart data available.
  • SX5PEX:GR 30.8850
  • 1D
  • 1M
  • 1Y
30.8500
Interactive SX5PEX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SX5PEX

iShares STOXX Europe 50 UCITS ETF (DE) is an open-end, UCITS compliant exchange traded fund incorporated in Germany. The fund aims to track the performance of the STOXX Europe 50 index. The fund distributes income received to shareholders.

Inception Date: 2001-01-03 Telephone: 49-89-427-29-5858
Managers: -
Web Site: www.iShares.com

Fundamentals for SX5PEX

NAV (on 2014-09-17) 30.8500
Assets (M) (on 2014-09-17) 564.6455
Shares out (M) 18.30
Market Cap (M) 565.47
% Premium 0.16
Average 52-Week % Premium 0.0314
Fund Leveraged N

Dividends for SX5PEX

Dividend Type Income
Dividend Frequency 3x a yr
Last Dividend Net (on 2014-09-15) 0.2418
Dividend Yield (ttm) 2.81%

Performance for SX5PEX

1-Month +5.11% 1-Year +13.80%
3-Month +1.11% 3-Year +16.20%
Year To Date +8.30% 5-Year +7.85%
Expense Ratio 0.52

Top Fund Holdings for SX5PEX

Filing Date: 09/16/2014
Name Position Value % of Total
Novartis AG 459,093 33,317,037 5.925%
Nestle SA 547,041 32,098,952 5.708%
Roche Holding AG 119,199 27,356,100 4.865%
HSBC Holdings PLC 3,234,910 26,720,522 4.752%
Royal Dutch Shell PLC 667,659 20,176,655 3.588%
Total SA 403,205 20,105,817 3.575%
BP PLC 3,123,899 18,489,552 3.288%
Sanofi 204,449 17,684,839 3.145%
Banco Santander SA 1,997,940 15,232,295 2.709%
GlaxoSmithKline PLC 828,845 14,965,899 2.661%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil